1.34
Schlusskurs vom Vortag:
$1.47
Offen:
$1.48
24-Stunden-Volumen:
3.33M
Relative Volume:
0.19
Marktkapitalisierung:
$130.72M
Einnahmen:
$1.20M
Nettoeinkommen (Verlust:
$-52.41M
KGV:
-1.4725
EPS:
-0.91
Netto-Cashflow:
$-31.25M
1W Leistung:
-15.72%
1M Leistung:
-36.79%
6M Leistung:
+139.07%
1J Leistung:
-22.99%
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Firmenname
Rani Therapeutics Holdings Inc
Sektor
Branche
Telefon
(408) 457-3700
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Vergleichen Sie RANI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
RANI
Rani Therapeutics Holdings Inc
|
1.34 | 143.40M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-14 | Eingeleitet | Maxim Group | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-10-11 | Eingeleitet | UBS | Buy |
| 2022-07-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Rani Therapeutics (NASDAQ:RANI) Stock Price Up 1.3%Here's Why - MarketBeat
Hedge Fund Bets: Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Quarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - moha.gov.vn
RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal - ts2.tech
Block Trades: Can Rani Therapeutics Holdings Inc. stock beat market expectations this quarterTrade Signal Summary & Weekly Momentum Picks - BỘ NỘI VỤ
Rani Therapeutics to Participate in the Evercore Healthcare Conference - The Manila Times
Why Is Rani Therapeutics’ Stock Skyrocketing Pre-Market Today? - MSN
What drives Rani Therapeutics Holdings Inc stock pricePrice-to-Earnings Ratio Insights & Minimal Investment Portfolio Growth - earlytimes.in
Will Rani Therapeutics Holdings Inc. stock gain from government policiesMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Is Rani Therapeutics Holdings Inc. stock trading at a premium valuationEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts - ts2.tech
How Rani Therapeutics Holdings Inc. stock compares to market leadersQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
How high can Rani Therapeutics Holdings Inc. stock goLong Setup & Consistent Income Trade Ideas - newser.com
Short interest data insights for Rani Therapeutics Holdings Inc.July 2025 Market Mood & Weekly Momentum Picks - newser.com
How Rani Therapeutics Holdings Inc. stock benefits from global expansionVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
Vasudev Jaiprakash Bailey Net Worth (2025) - GuruFocus
Will Rani Therapeutics Holdings Inc. bounce back from current supportStock Surge & AI Forecasted Entry/Exit Points - newser.com
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis toolsJuly 2025 Drop Watch & Low Drawdown Investment Strategies - newser.com
Rani Therapeutics Holdings (RANI) Price Target Decreased by 11.90% to 9.44 - MSN
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipeline2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryGap Up & Safe Entry Trade Reports - Fundação Cultural do Pará
Investors Purchase High Volume of Put Options on Rani Therapeutics (NASDAQ:RANI) - MarketBeat
Will Rani Therapeutics Holdings Inc. stock attract more institutional investorsJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
MSN Money - MSN
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rani Therapeutics Holdings Inc-Aktie (RANI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner |
Oct 21 '25 |
Sale |
2.77 |
4,000,000 |
11,074,000 |
2,379,194 |
| South Cone Investments Limited | 10% Owner |
Oct 20 '25 |
Sale |
2.41 |
1,923,000 |
4,637,314 |
6,379,194 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):